Abstract
Purpose
Anticoagulation-associated adverse drug events are common in hospitalised patients and result in morbidity, mortality, increased length of hospital stay and higher costs of care. Many are preventable. We reviewed the literature to identify and assess interventions intended to improve safety or quality anticoagulant prescribing.
Methods
A systematic search of EMBASE, MEDLINE, the Cochrane Library, Pretty Darn Quick-Evidence and Health Systems Evidence was undertaken to identify controlled studies assessing system-level interventions to improve prescribing of oral or parenteral therapeutic anticoagulation for any indication in hospitalised adults. Data were extracted for safety and quality outcomes, with studies grouped by intervention type for meta-analysis and narrative review.
Results
Of 10,640 records screened, 19 trials evaluating 12,742 participants were included for analysis. No study specifically evaluated prescribing of low molecular weight heparins (LMWHs) or direct acting oral anticoagulants (DOACs). Our findings suggest that physician-led anticoagulation consultation services may reduce bleeding rates in high-risk patients. On meta-analysis, decision supported warfarin dosing resulted in higher proportion of time with international normalised ratio in therapeutic range (p = 0.0007). Studies of other clinical decision support systems and heparin monitoring systems did not demonstrate improved safety, and quality findings were inconsistent. Systematic education and feedback programs were not efficacious.
Conclusions
There is currently insufficient high-quality evidence to recommend any reviewed intervention, though several warrant closer evaluation. Adequately powered controlled trials assessing safety outcomes and evidence-based quality markers in high-risk patient groups and studies of interventions to improve safety of LMWH and DOAC prescribing are needed.
Similar content being viewed by others
References
van Walraven C, Austin PC, Oake N, Wells P, Mamdani M, Forster AJ (2007) The effect of hospitalization on oral anticoagulation control: a population-based study. Thromb Res 119(6):705–714
Henriksen JN, Nielsen LP, Hellebek A, Poulsen BK (2017) Medication errors involving anticoagulants: data from the Danish patient safety database. Pharmacol Res Perspect 5(3):e00307
Classen DC, Jaser L, Budnitz DS (2010) Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf 36(1):12–21
Piazza G, Nguyen TN, Cios D, Labreche M, Hohlfelder B, Fanikos J, Fiumara K, Goldhaber SZ (2011) Anticoagulation-associated adverse drug events. Am J Med 124(12):1136–1142
Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD (1995) The quality in Australian health care study. Med J Aust 163(9):458–471
Eckman MH, Levine HJ, Salem DN, Pauker SG (1998) Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest 114(5 Suppl):699S–714S
Conway SE, Hwang AY, Ponte CD, Gums JG (2017) Laboratory and clinical monitoring of direct acting Oral anticoagulants: what clinicians need to know. Pharmacotherapy 37(2):236–248
Duplaga BA, Rivers CW, Nutescu E (2001) Dosing and monitoring of low-molecular-weight heparins in special populations. Pharmacotherapy 21(2):218–234
Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE (1998) Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 114(5 Suppl):489S–510S
Hoffmann P, Keller F (2012) Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysis. Eur J Clin Pharmacol 68(5):757–765
DeCarolis DD, Thorson JG, Clairmont MA, Leuthner AM, Rector TS, Johnson GJ (2012) Enoxaparin outcomes in patients with moderate renal impairment. Arch Intern Med 172(22):1713–1718
LaPointe NM, Chen AY, Alexander KP, Roe MT, Pollack CV Jr, Lytle BL et al (2007) Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. Arch Intern Med 167(14):1539–1544
Zaidenstein R, Eyal S, Efrati S, Akivison L, Michowitz MK, Nagornov V et al (2002) Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants. Pharmacoepidemiol Drug Saf 11(3):235–238
Spector WD, Limcangco R, Furukawa MF, Encinosa WE (2017) The marginal costs of adverse drug events associated with exposures to anticoagulants and hypoglycemic agents during hospitalization. Med Care 55(9):856–863
The Joint Commission (2019) National Patient Safety Goals Effective January 2019: Hospital Accreditation Program. https://www.jointcommission.org/assets/1/6/NPSG_Chapter_HAP_Jan2019.pdf. Accessed 12 Jan 2019
ACSQHC (2018)Australian Commission on Safety and Quality in Health Care: Annual Report 2017–2018. https://www.safetyandquality.gov.au/wp-content/uploads/2018/10/ACSQHC_Annual_Report_2017-2018.pdf. Accessed 12 Jan 2019
Aronson JK (2012) Balanced prescribing – principles and challenges. Br J Clin Pharmacol 74(4):566–572
Fennerty A, Dolben J, Thomas P, Backhouse G, Bentley DP, Campbell IA, Routledge PA (1984) Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) 288(6426):1268–1270
Zimmermann AT, Jeffries WS, McElroy H, Horowitz JD (2003) Utility of a weight-based heparin nomogram for patients with acute coronary syndromes. Intern Med J 33(1–2):18–25
Tran H, Joseph J, Young L, McRae S, Curnow J, Nandurkar H, Wood P, McLintock C (2014) New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis. Intern Med J 44(6):525–536
Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A (2016) Wittkowsky AK (2016) guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis 41(1):165–186
Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism. J Thromb Thrombolysis 41(1):187–205
Kew GS, Tan M, Lim TW (2015) Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unit. Heart Asia 7(1):18–22
McBride D, Bruggenjurgen B, Roll S, Willich SN (2007) Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis 24(1):65–72
Wan D, Healey JS, Simpson CS (2018) The guideline-policy gap in direct-acting Oral anticoagulants usage in atrial fibrillation: evidence, Practice, and public policy considerations. Can J Cardiol 34(11):1412–1425
Bradley G (1998) An audit of anticoagulant guidelines: the relative influence of education, presentation and complexity of guidelines on compliance. J Clin Eff 3(2):84–89
Maynard G, Humber D, Jenkins I (2014) Multidisciplinary initiative to improve inpatient anticoagulation and management of venous thromboembolism. Am J Health Syst Pharm 71(4):305–310
Schurr JW, Stevens CA, Bane A, Luppi C, Culbreth SE, Miller AL, Connors JM, Sylvester KW (2018) Description and evaluation of the implementation of a weight-based, nurse-driven heparin nomogram in a tertiary Academic Medical Center. Clin Appl Thromb Hemost 24(2):248–253
Enriquez JR, de Lemos JA, Parikh SV, Simon DN, Thomas LE, Wang TY et al Modest Associations Between Electronic Health Record Use and Acute Myocardial Infarction Quality of Care and Outcomes: Results From the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 8(6):576–585
Oyen LJ, Nishimura RA, Ou NN, Armon JJ, Zhou M (2005) Effectiveness of a computerized system for intravenous heparin administration: using information technology to improve patient care and patient safety. The Am Heart Hosp J 3(2):75–81
Nieuwlaat R, Connolly SJ, Mackay JA, Weise-Kelly L, Navarro T, Wilczynski NL et al (2011) Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review. Implement Sci 6:90
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269 W64
United Nations (2018) World economic situation and prospects 2018, UN, New York https://www.un.org/development/desa/dpad/wp-content/uploads/sites/45/publication/WESP2018_Full_Web-1.pdf. Accessed 6 July 2019
Cochrane Effective Practice and Organisation of Care group (2017) What study designs can be considered for inclusion in an EPOC review and what should they be called? EPOC resources for review authors. Norwegian Knowledge Centre for the Health Services. http://epoc.cochrane.org/resources/epoc-resources-review-authors. Accessed 12 Jan 2019
Cochrane Effective Practice and Organisation of Care group (2013) Data collection form. EPOC Resources for review authors. Norwegian Knowledge Centre for the Health Services. http://epoc.cochrane.org/epoc-specific-resources-review-authors. Accessed 12 Jan 2019
Cochrane Effective Practice and Organisation of Care group (2017) Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Norwegian Knowledge Centre for the Health Services. http://epoc.cochrane.org/resources/epoc-resources-review-authors. Accessed 12 Jan 2019
Cochrane Collaboration (2014) Review Manager (RevMan) [Computer program]. Version 5.3. The Nordic Cochrane Centre, Copenhagen
Higgins JPT, Green S (editors) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration www.handbook.cochrane.org. Accessed 12 Jan 2019
Chenella FC, Klotz TA, Gill MA (1983) Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. Am J Hosp Pharm 40(10):1642–1645
Landefeld CS, Anderson PA (1992) Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital. Ann Intern Med 116(10):829–837
Ageno W, Johnson J, Nowacki B, Turpie AG (2000) A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy. Thromb Haemost 83(6):849–852
Carter BL, Taylor JW, Becker A (1987) Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy. Clin Pharm 6(1):37–45
Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane R, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER III, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA III, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH, COAG Investigators (2013) A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 369(24):2283–2293
Mitra R, Marciello MA, Brain C, Ahangar B, Burke DT (2005) Efficacy of computer-aided dosing of warfarin among patients in a rehabilitation hospital. Am J Phys Med Rehabili 84(6):423–427
Ovesen L, Lyduch S, Ott P (1989) A simple technique for predicting maintenance dosage of warfarin - is it better than empirical dosing? Eur J Clin Pharmacol 37(6):573–576
Vadher B, Patterson DL, Leaning M (1997) Evaluation of a decision support system for initiation and control of oral anticoagulation in a randomised trial. BMJ 314(7089):1252–1256
White RH, Hong R, Venook AP, Daschbach MM, Murray W, Mungall DR, Coleman RW (1987) Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. J Gen Intern Med 2(3):141–148
Becker R, Ball S, Eisenberg P, Borzak S, Held A, Spencer F et al (1999) A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic therapy consortium investigators. Am Heart J 137(1):59–71
Panigada M, E Iapichino G, Brioni M, Panarello G, Protti A, Grasselli G et al (2018) Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study. Ann Intensive Care 8(1):7
Rosborough T (1999) Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time. Pharmacotherapy 19(6):760–766
Silbernagel G, Spirk D, Hager A, Baumgartner I, Kucher N (2016) Electronic alert system for improving stroke prevention among hospitalized Oral-anticoagulation-Naïve patients with atrial fibrillation: a randomized trial. J Am Heart Assoc 5(7):e003776
Strom BL, Schinnar R, Bilker W, Hennessy S, Leonard CE, Pifer E (2010) Randomized clinical trial of a customized electronic alert requiring an affirmative response compared to a control group receiving a commercial passive CPOE alert: NSAID--warfarin co-prescribing as a test case. J Am Med Inform Assoc 17(4):411–415
Strom B, Schinnar R, Aberra F, Bilker W, Hennessy S, Leonard C et al (2010) Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med 170(17):1578–1583
Schillig J, Kaatz S, Hudson M, Krol G, Szandzik E, Kalus J (2011) Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med 6(6):322–328
Weir CJ, Lees KR, MacWalter RS, Muir KW, Wallesch CW, McLelland EV, Hendry A, PRISM Study Group (2003) Cluster-randomized, controlled trial of computer-based decision support for selecting long-term anti-thrombotic therapy after acute ischaemic stroke. QJM 96(2):143–153
Garrouste-Orgeas M, Soufir L, Tabah A, Schwebel C, Vesin A, Adrie C, Thuong M, Timsit JF, Outcomerea Study Group (2012) A multifaceted program for improving quality of care in intensive care units: IATROREF study. Crit Care Med 40(2):468–476
Hayes R, Bratzler D, Armour B, Moore L, Murray C, Stevens BR, Radford M, Fitzgerald D, Elward K, Ballard DJ (2001) Comparison of an enhanced versus a written feedback model on the management of Medicare inpatients with venous thrombosis. Jt Comm J Qual Improv 27(3):155–168
Middeldorp S, Prins MH, Hutten BA (2014) Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database Syst Rev 8:CD001367
Chai-Adisaksopha C, Crowther M, Isayama T, Lim W (2014) The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 124(15):2450–2458
Lee T, Davis E, Kielly J (2016) Clinical impact of a pharmacist-led inpatient anticoagulation service: a review of the literature. Integr Pharm Res Pract 5:53–63
Kershaw B, White RH, Mungall D, Van Houten J, Brettfeld S (1994) Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Arch Intern Med 154(9):1005–1011
Pawloski SJ, Kersh PL (1992) Therapeutic heparin monitoring service in a small community hospital. Hosp Pharm 27(8):703–706 23
Bloomfield HE, Taylor BC, Krause A, Reddy P, Greer N, MacDonald R et al (2011) Safe and effective anticoagulation in the outpatient setting: a systematic review of the evidence. United States Department of Veteran Affairs, Washington DC. https://www.ncbi.nlm.nih.gov/books/NBK54599/. Accessed 14 Jan 2019
Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E et al (2017) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2:CD003543
Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L (2004) Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest 126(6):1938–1945
Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 333(1):11–17
Raschke R, Reilly B, Guidry J, Fontana J, Srinivas S (1993) The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 119(9):874–881
Nuckols TK, Smith-Spangler C, Morton SC, Asch SM, Patel VM, Anderson LJ, Deichsel EL, Shekelle PG (2014) The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev 3:56
Ranji SR, Rennke S, Wachter RM (2014) Computerised provider order entry combined with clinical decision support systems to improve medication safety: a narrative review. BMJ Qual Saf 23(9):773–780
Campbell EM, Sittig DF, Ash JS, Guappone KP, Dykstra RH (2006) Types of unintended consequences related to computerized provider order entry. J Am Med Inform Assoc 13(5):547–556
Slikkerveer M, van de Plas A, Driessen JHM, Wijngaard R, de Vries F, Olie R et al (2017) Prescribing errors with low-molecular-weight heparins. J Patient Saf. https://doi.org/10.1097/PTS.0000000000000417
Pattullo CS, Barras M, Tai B, McKean M, Donovan P (2016) New oral anticoagulants: appropriateness of prescribing in real-world setting. Intern Med J 46(7):812–818
Moudallel S, Steurbaut S, Cornu P, Dupont A (2018) Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing. Front Pharmacol 9:1220
Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J et al (2018) Frequency and outcomes of reduced dose non-vitamin K antagonist anticoagulants: results from ORBIT-AF II (the outcomes registry for better informed treatment of atrial fibrillation II). J Am Heart Assoc 7(4):e007633
Acknowledgements
The authors greatly appreciate the assistance of Sue Sacre and Jasmin Monaghan (Graphic Designers at Clinical Multimedia, The Royal Brisbane and Women’s Hospital) with reformatting of images for publication.
Author information
Authors and Affiliations
Contributions
All authors have made substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data. All were involved with drafting the work or revising it critically for important intellectual content and have given final approval of the version published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing interest
The authors declare that they have no competing interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Frazer, A., Rowland, J., Mudge, A. et al. Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. Eur J Clin Pharmacol 75, 1645–1657 (2019). https://doi.org/10.1007/s00228-019-02752-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-019-02752-8